MET and colorectal cancer: For further comparison, increased MET gene CN measured by fluorescence in situ hybridization was found in 1 to 4% of tumors from NSCLCs [30], 8.5% of lung sarcomatoid carcinomas [35], and 4.2% of colorectal cancer tissue samples [36].